An improved customizable dosage form comprising a substrate, such as a tablet core, that has one or more distinct, discreet cavities on its exterior surface, wherein simethicone is deposited into at least one of the cavities.

An improved customizable dosage form comprising a substrate, such as a tablet core, that has one or more distinct, discreet cavities on its exterior surface, wherein simethicone is deposited into at least one of the cavities.

A non-aqueous gel composition comprising silicone crosspolymer, silicone oil and a sweat and/or sebum absorbing agent wherein the composition is used to prevent or treat symptoms associated with a topical skin disorder in a human patient. The present invention also relates to method of preventing or treating a topical skin disorder using a non-aqueous gel composition.

A non-aqueous gel composition comprising silicone crosspolymer, silicone oil and a sweat and/or sebum absorbing agent wherein the composition is used to prevent or treat symptoms associated with a topical skin disorder in a human patient. The present invention also relates to method of preventing or treating a topical skin disorder using a non-aqueous gel composition.

The disclosure relates to cationic polymers functionalized with substituted phenylboronic acid groups and to methods of using the same to treat metabolic and gastrointestinal disorders.

The disclosure relates to cationic polymers functionalized with substituted phenylboronic acid groups and to methods of using the same to treat metabolic and gastrointestinal disorders.

The disclosure relates to cationic polymers functionalized with substituted phenylboronic acid groups and to methods of using the same to treat metabolic and gastrointestinal disorders.

The disclosure relates to cationic polymers functionalized with substituted phenylboronic acid groups and to methods of using the same to treat metabolic and gastrointestinal disorders.

Polyphosphazene polymers having immunomodulating activity, and the biomedical use of such polyphosphazene polymers, in conjunction with an antigen or an immunogen are disclosed.

Polyphosphazene polymers having immunomodulating activity, and the biomedical use of such polyphosphazene polymers, in conjunction with an antigen or an immunogen are disclosed.